143 related articles for article (PubMed ID: 35771366)
21. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
[TBL] [Abstract][Full Text] [Related]
22. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
Kim H; Myoung S; Koom WS; Kim NK; Kim MJ; Ahn JB; Hur H; Lim JS
PLoS One; 2016; 11(1):e0146235. PubMed ID: 26730717
[TBL] [Abstract][Full Text] [Related]
23. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
24. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
[TBL] [Abstract][Full Text] [Related]
25. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
28. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters.
Hötker AM; Tarlinton L; Mazaheri Y; Woo KM; Gönen M; Saltz LB; Goodman KA; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2016 Dec; 26(12):4303-4312. PubMed ID: 26945761
[TBL] [Abstract][Full Text] [Related]
30. MRI Tumor Regression Grade Combined with T2-Weighted Volumetry May Predict Histopathological Response in Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy-A New Scoring System Proposal.
Jankovic A; Kovac JD; Dakovic M; Mitrovic M; Saponjski D; Milicevic O; Djuric-Stefanovic A; Barisic G
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892047
[TBL] [Abstract][Full Text] [Related]
31. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
[TBL] [Abstract][Full Text] [Related]
32. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
33. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
34. Do treated rectal tumors appear differently on MRI after chemotherapy versus chemoradiotherapy?
Shen Y; Wen Y; Bi L; Yang X; Gong X; Deng X; Meng W; Wang Z
Abdom Radiol (NY); 2024 Mar; 49(3):774-782. PubMed ID: 37999742
[TBL] [Abstract][Full Text] [Related]
35. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.
Khakoo S; Carter PD; Brown G; Valeri N; Picchia S; Bali MA; Shaikh R; Jones T; Begum R; Rana I; Wotherspoon A; Terlizzo M; von Loga K; Kalaitzaki E; Saffery C; Watkins D; Tait D; Chau I; Starling N; Hubank M; Cunningham D
Clin Cancer Res; 2020 Jan; 26(1):183-192. PubMed ID: 31852830
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.
Chang GJ; You YN; Park IJ; Kaur H; Hu CY; Rodriguez-Bigas MA; Skibber JM; Ernst RD
Dis Colon Rectum; 2012 Apr; 55(4):371-7. PubMed ID: 22426259
[TBL] [Abstract][Full Text] [Related]
37. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG).
Siddiqui MR; Gormly KL; Bhoday J; Balyansikova S; Battersby NJ; Chand M; Rao S; Tekkis P; Abulafi AM; Brown G
Clin Radiol; 2016 Sep; 71(9):854-62. PubMed ID: 27381221
[TBL] [Abstract][Full Text] [Related]
38. Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial.
Nougaret S; Castan F; de Forges H; Vargas HA; Gallix B; Gourgou S; Rouanet P;
Br J Surg; 2019 Oct; 106(11):1530-1541. PubMed ID: 31436325
[TBL] [Abstract][Full Text] [Related]
39. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
40. MRI response rate after short-course radiotherapy on rectal cancer in the elderly comorbid patient: results from a retrospective cohort study.
Koëter T; van Elderen SGC; van Tilborg GFAJB; de Wilt JHW; Wasowicz DK; Rozema T; Zimmerman DDE
Radiat Oncol; 2020 Mar; 15(1):53. PubMed ID: 32122381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]